General Practitioners’ Perspectives on Digital Health Applications for Mental Disorders and Their Prescribing Behavior: Mixed Methods Study
JMIR Mental Health · 2026
DOI: 10.2196/78659 ↗Kurz gefasst
Mixed-Methods-Studie in der Zeitschrift JMIR Mental Health, 2026. Verfasst von Sandy Scheibe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Practice, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Fetscherstraße 7…. Hauptthemen laut MEDLINE: General Practitioners, Mental Disorders, Attitude of Health Personnel, Practice Patterns, Physicians'. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
Background
The high number of mental disorders poses challenges for health care systems. In 2020, digital health applications (DHAs) were introduced in Germany as a new form of health care financed by the statutory health insurance. They aim to detect, monitor, treat, or alleviate disease, injury, or disability. DHAs for mental disorders (DHA-MD) intend to improve outpatient care for patients with mental disorders. However, evidence on general practitioners’ (GPs’) perspectives on DHA-MD and their prescribing behavior is limited.
Objective
This study aimed to analyze GPs’ perspectives on DHA-MD and their prescribing behavior in the care of patients with mental disorders.
Methods
A mixed methods study was conducted (January-October 2024), including a Germany-wide online survey and qualitative interviews with GPs and medical assistants (MAs). Sampling was conducted in collaboration with German research practice networks, which distributed the study invitation to their affiliated GPs. The questionnaire as well as the interview guides for GPs and MAs was developed by the study team according to the Consolidated Framework for Implementation Research. Descriptive analyses of prescribing behavior and perceived need (measured on an 11-point scale) for DHA-MD were conducted, followed by multivariate regression analyses to identify predictors of prescribing behavior and perceived need for DHA-MD. The interviews with GPs and MAs were analyzed using qualitative content analysis according to Mayring.
Results
A sample of 149 GPs participated, and 12 GPs as well as 5 MAs were interviewed. The median prescription frequency of DHA-MD per quarter was 1, whereas the median estimated need was 3. Working in a half digitized and half paper-based practice (odds ratio 5.133, 95% CI 1.695‐15.542) as well as working in a completely digitized practice (odds ratio 3.006, 95% CI 1.296‐6.969) positively predicted the prescribing behavior. The duration of GPs’ medical practice ( b =−0.057; P =.01) negatively predicted the perceived need, while working in a group practice ( b =0.980; P =.02) positively predicted the perceived need for DHA-MD. In the interviews, GPs and MAs reported that they valued DHA-MD as a temporary or supplementary option for bridging waiting times for psychotherapy and considered their effectiveness to be highly dependent on indication and patient adherence. Reported barriers of GPs according to DHA-MD included lacking knowledge about DHA-MD, missing effectiveness studies, and difficulties integrating them into existing care processes.
Conclusions
GPs are reluctant to prescribe DHA-MD, as the need is considered to be low and their use is primarily seen as a temporary or supplementary treatment option rather than a stand-alone intervention. There are significant reasons for rejection and barriers that hinder prescription in primary care. Addressing these barriers and involving GPs as well as patients in future research are essential for the development of DHA-MD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Practice, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Fetscherstraße 74, 01307 Dresden, Germany, 49 351-45889240, 49 351-4588836.
- Institute of General Practice, Goethe University Frankfurt, Frankfurt am Main, Germany.
- Medical Psychology-Neuropsychology and Gender Studies and Center for Neuropsychological Diagnostics and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Köln, Germany.
- Division of Epidemiology and Health Services Research, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
- Department of Consultation-Liaison-Psychiatry and Psychosomatic Medicine, University Hospital of Zürich, Zürich, Switzerland.
- Department of Psychology, Clinical Psychology and Psychotherapy-Methods and Approaches, Trier University, Trier, Germany.
Zitieren
APA
Scheibe, S., Salm, S., Mergenthal, K., Engesser, D., Stalujanis, E., Singer, S., Kemmerer, P., Dotzauer, L., & Voigt, K. (2026). General Practitioners’ Perspectives on Digital Health Applications for Mental Disorders and Their Prescribing Behavior: Mixed Methods Study. JMIR Mental Health. https://doi.org/10.2196/78659
Vancouver
Scheibe S, Salm S, Mergenthal K, Engesser D, Stalujanis E, Singer S, et al. General Practitioners’ Perspectives on Digital Health Applications for Mental Disorders and Their Prescribing Behavior: Mixed Methods Study. JMIR Mental Health. 2026. doi:10.2196/78659
BibTeX
@article{Scheibe2026,
author = {Scheibe, Sandy and Salm, Sandra and Mergenthal, Karola and Engesser, Deborah and Stalujanis, Esther and Singer, Susanne and Kemmerer, Pascal and Dotzauer, Lena and Voigt, Karen},
title = {General Practitioners’ Perspectives on Digital Health Applications for Mental Disorders and Their Prescribing Behavior: Mixed Methods Study},
journal = {JMIR Mental Health},
year = {2026},
doi = {10.2196/78659}
}
EUVIMED